Biophysical Measurement Strategies for Antiviral Drug Development: Recent Progress in Virus-Mimetic Platforms Down to the Single Particle Level
- PMID: 34346210
- DOI: 10.1021/acs.accounts.1c00300
Biophysical Measurement Strategies for Antiviral Drug Development: Recent Progress in Virus-Mimetic Platforms Down to the Single Particle Level
Abstract
The rapid growth in the global human population has increased the prevalence of emerging infectious diseases, which poses a major risk to public health. In search of effective clinical solutions, the acquisition of knowledge and understanding of biomolecular processes associated with viral pathogens represents a prerequisite. In this context, biophysical engineering approaches are particularly promising since they can resolve biomolecular interactions systematically by circumventing the complexities associated with experiments involving natural biological systems. The engineering approaches encompass the design and construction of biomimetic platforms that simulate the physiological system. This approach enables us to characterize, measure, and quantitatively analyze biomolecular interactions.In this Account, we summarize biophysical measurements that our group has successfully adopted to develop broad-spectrum antiviral drugs based on the lipid envelope antiviral disruption (LEAD) strategy, targeting the structural integrity of the outer viral membrane to abrogate viral infectivity. We particularly focus on the engineering aspects related to the design and construction of the tethered lipid vesicle platform, which closely mimics the viral membrane. We first outline the development of the LEAD agents screening platform that integrates soft matter design components with biomaterials and surface functionalization strategies to facilitate parallel measurements tracking peptide-induced destabilization of nanoscale, virus-mimicking vesicles with tunable size and composition. Then, we describe how this platform can be effectively employed to gain insights into the membrane curvature dependency of certain peptides. The fundamental knowledge acquired through this systematic process is crucial in the identification and subsequent development of antiviral drug candidates. In particular, we highlight the development of curvature-sensitive α-helical (AH) peptides as a broad-spectrum antiviral agent that has been demonstrated as an effective therapeutic treatment against multiple enveloped viruses. Also, we introduce a tethered cluster of vesicles to mimic clusters of enveloped viruses, exhibiting higher infectivity levels in the biological system. Then, we discuss key considerations, including experimental artifacts, namely dye leakage and imaging-related photobleaching, and corresponding corrective measures to improve the accuracy of quantitative interpretation. With the ongoing development and application of the tethered lipid vesicle platform, there is a compelling opportunity to explore fundamental biointerfacial science and develop a new class of broad-spectrum antiviral agents to prepare for the future membrane-enveloped viral pandemics.
Similar articles
-
Antiviral peptide engineering for targeting membrane-enveloped viruses: Recent progress and future directions.Biochim Biophys Acta Biomembr. 2022 Feb 1;1864(2):183821. doi: 10.1016/j.bbamem.2021.183821. Epub 2021 Nov 19. Biochim Biophys Acta Biomembr. 2022. PMID: 34808121 Review.
-
Stopping Membrane-Enveloped Viruses with Nanotechnology Strategies: Toward Antiviral Drug Development and Pandemic Preparedness.ACS Nano. 2021 Jan 26;15(1):125-148. doi: 10.1021/acsnano.0c07489. Epub 2020 Dec 11. ACS Nano. 2021. PMID: 33306354 Review.
-
Comparing the Membrane-Interaction Profiles of Two Antiviral Peptides: Insights into Structure-Function Relationship.Langmuir. 2019 Jul 30;35(30):9934-9943. doi: 10.1021/acs.langmuir.9b01052. Epub 2019 Jul 19. Langmuir. 2019. PMID: 31291111
-
Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).Phys Biol. 2013 Aug;10(4):040301. doi: 10.1088/1478-3975/10/4/040301. Epub 2013 Aug 2. Phys Biol. 2013. PMID: 23912807
-
Model membrane platforms for biomedicine: case study on antiviral drug development.Biointerphases. 2012 Dec;7(1-4):18. doi: 10.1007/s13758-011-0018-2. Epub 2012 Feb 11. Biointerphases. 2012. PMID: 22589061 Free PMC article. Review.
Cited by
-
Dietary Supplementation of Aspirin Promotes Drosophila Defense against Viral Infection.Molecules. 2023 Jul 9;28(14):5300. doi: 10.3390/molecules28145300. Molecules. 2023. PMID: 37513173 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources